PotNetwork Holding Inc. Strengthens Board of Advisors with the Appointment of Dr. David Feldbaum
August 23 2017 - 9:50AM
InvestorsHub NewsWire
South Florida Vascular
Surgeon Joins
PotNetwork Advisory Board, Bringing Advanced Understanding to
Diamond CBD’s Team
Ft
Lauderdale, FL -- August 23, 2017 -- InvestorsHub NewsWire
-- PotNetwork Holding
Inc. (OTC
Pink: POTN)
today announces that as part of its strategy to
formulate, produce and market a spectrum of exclusive and diversely
targeted cannabidiol blends, the Company has added Dr. David M.
Feldbaum MD, FACS to its Board of Advisors.
Dr. Feldbaum is certified in vascular surgery by
the American Board of Surgery. He completed a surgical residency at
Montefiore Medical Center/Albert Einstein College of Medicine in
New York City, as well as a vascular surgery fellowship at the
Carolinas Heart Institute in North Carolina. Dr. Feldbaum is
affiliated with the Memorial Healthcare System and the Westside
Regional Medical Center, and is also a member of the voluntary
faculty clinical instructor of surgery at the University of Miami
School of Medicine.
PotNetwork’s newly formed advisory board was
created to provide its subsidiary, Diamond CBD, Inc., with guidance
and insight on upcoming formulations. On par with this strategy,
Dr. Feldbaum’s expertise contributes to Diamond CBD
substantial knowledge of the intricacies of
vascular health and an acquired understanding of how CBD components
can contribute to the optimization of results in his area of
expertise.
“We are very pleased to have Dr. Feldbaum join
our growing team of advisors. We expect that his experience and
wisdom will strengthen the Company’s position in the industry as we
target product lines to enhance wellness in his areas of
expertise,” states Maria Gomez, Regional Vice President of Sales
for Diamond CBD.
CBD research demonstrates its potential to
provide symptomatic relief for a wide range of ailments, including
rheumatoid arthritis, diabetes, alcoholism, post traumatic stress
disorder, epilepsy, antibiotic-resistant infections, neurological
disorders, and muscular dystrophy, among many others. Diamond CBD
is focused on continuing this research to develop premium hemp
extracts that contain a broad range of cannabinoids and natural
hemp derivatives to potentially address these key
markets.
“This is an exciting time to be on the forefront
of the CBD revolution. Being instrumental in the development of
such cutting-edge developments, I believe we are enabled to make a
difference in the quality of life for many. We stand at the
threshold of great new discoveries,” states Dr.
Feldbaum.
About Diamond CBD
Inc.: Diamond CBD focuses on the
research, development, and multi-national marketing of premium hemp
extracts that contain a broad range of cannabinoids and natural
hemp derivatives. Diamond CBD’s team consists of hemp
industry pioneers and natural product experts, chemists, and
scientists, dedicated to producing the finest and purest
cannabidiol (CBD) oils. The result is a robust
selection considered among the most powerful natural
CBD
oils and E-Liquids found anywhere.
For more information, please visit its website
at www.DiamondCBD.com.
About PotNetwork Holding
Inc: PotNetwork Holding Inc. (OTC Pink:
POTN) is a
publicly traded company that acts as a holding company for its
subsidiaries, First Capital Venture Co., the owner of Diamond CBD,
Inc., the maker of Diamond CBD oils.
Safe Harbor Act: Forward-Looking
Statements are included within the meaning of Section 27A of the
Securities Act of 1933, and Section 21E of the Securities Exchange
Act of 1934, as amended. All statements regarding our expected
future financial position, results of operations, cash flows,
financing plans, business strategy, products and services,
competitive positions, growth opportunities, plans and objectives
of management for future operations, including words such as
"anticipate," "if," "believe," "plan," "estimate," "expect,"
"intend," "may," "could," "should," "will," and similar expressions
are forward-looking statements and involve risks, uncertainties and
contingencies, many of which are beyond our control, which may
cause actual results, performance, or achievements to differ
materially from anticipated results, performance, or achievements.
We are under no obligation to (and expressly disclaim any such
obligation to) update or alter forward-looking statements, whether
as a result of new information, future events or
otherwise.
Contact:
PotNetwork Holding Inc. Investor Relations:
Marisol Elwell, 1-800-915-3060
investor@PotNetworkHolding.com
Potnetwork (CE) (USOTC:POTN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Potnetwork (CE) (USOTC:POTN)
Historical Stock Chart
From Sep 2023 to Sep 2024